STRONG BUY On NVO Stock: Dips Like These Come Once Every Few Years

Hey everyone, I recently gave a Strong Buy rating to Novo Nordisk stock (NVO), as it’s a growing blue-chip stock that’s well off its highs, trading at a PEG ratio of less than 1.0x, which is great for such a dominant company. If you don’t know what Novo Nordisk does, it’s the company behind the famous Ozempic weight-loss drug. There’s lots of growth potential in weight-loss drugs.

Following the stock’s fall, its PE ratio is now closer to historical averages, making it attractive.

I dropped some analysis on Seeking Alpha and made it free for you guys to read ⬇️